All issues > Volume 33(9); 1990
- Original Article
- J Korean Pediatr Soc. 1990;33(9):1255-1261. Published online September 30, 1990.
- Immunologic Changes in Bronchial Asthma on Immunotherapy.
- Joon Sung Lee1, Kyung Tai Whang1, Sung Hoon Cho1
- 1Department of Pediatrics, Catholic University Medical College, Seoul, Korea
- Received: March 6, 1990; Accepted: May 30, 1990.
- Abstract
- The best treatment of allergic disease is to avoid exposure to known allergen. Immunotherapy has
been attempted in IgE-mediated allergic patients who didn’t show any responses to pharmacologic
therapy or couldn’t avoid allergen.
There have been many enthusiastic claims for symptomatic relief of allergic disease by various
forms of hyposensitization, first introduced by Noon and Freeman (1911) in the treatment of hay
fever.
The mechanism of immunotherapy is not fully evaluated, but a number of immunologic changes
have been demonstrated. Among these changes are 1) A rise in allergen specific IgG antibody, 2) A
decrease in specific IgE antibody, 3) A decrease in basophil sensitivity, 4) Generation of specific
suppresor T cells.
We selected twenty asthmatic children who showed strong reactivity to Dermatophagoides pter-
onyssinus (Dp) on skin test and RAST and showed clinical improvement after 1 year immunotherapy.
We measured the levels of serum immunoglobulins and complement components before and after
immunotherapy and tried to evaluate the relationship between the immunologic changes and clinical
improvements.
The results are as follows:
1) Peripheral blood eosinophil count was decreased.
2) Serum IgG and IgA levels were increased slightly, but serum IgM and IgE levels were decreased.
3) C3, C4 levels were increased.
4) Dp-specific IgE level was decreased significantly (p=0.043).
5) Dp-specific IgG level was increased significantly (p=0.046).
6) Dp-specific IgG4 level was increased significantly (p=0.0097).
In conclusion, there are some changes of serum immunoglobulins in asthmatic children on im-
munotherapy and is close relationship between the efficacy of immunotherapy and the changes of
allergen specific immunoglobins.
Keywords :Immunotherapy, Dp-specific Immunoglobulin; IgE, IgG, IgG4